*
Walgreens edges past Wall St's lowered Q4 profit estimates
*
Forecasts adj EPS of $1.40-$1.80/shr, vs estimate of
$1.73/shr
*
Stock down 65% this year, worst performer on S&P 500 index
By Manas Mishra
Oct 15 (Reuters) - Walgreens Boots Alliance ( WBA ) said
on Tuesday it would shut 1,200 stores over the next three years
as new CEO Tim Wentworth plots a turnaround at the struggling
pharmacy chain operator hit by sluggish consumer spending and
low drug reimbursement rates.
The company also narrowly beat Wall Street's lowered
estimates for fourth-quarter adjusted profit, and forecast
fiscal-year earnings that were mostly in-line with expectations.
Pharmacy chains are facing their most turbulent time in
recent history as consumers avoid high-priced grocery items and
pressures mount on payments they receive from drug middlemen for
filling prescriptions.
As a result, Walgreens' stock is trading near 30-year lows
and down 65% this year, making it the worst performing stock on
the S&P 500 index.
CEO Wentworth has unveiled a series of changes since taking
on the top job last year, including the removal of multiple
mid-level executives and a $1 billion cost-cutting program.
"This turnaround will take time, but we are confident it
will yield significant financial and consumer benefits over the
long term," said Wentworth in a statement.
The closures were announced in June but the company had not
disclosed the number of affected stores at that time. It had
over 8,000 stores in the United States as of Aug. 31 last year.
In the fourth quarter of its fiscal year 2024, Walgreens
said it recorded impairment charges on the goodwill of home care
provider CareCentrix and equity investment in China.
Excluding those items and other charges, the company earned
39 cents per share on an adjusted basis. Analysts had expected a
profit of 36 cents per share, according to data compiled by
LSEG.
Comparable retail sales fell 1.7%, hurt by "a challenging
retail environment". Sales of groceries and other items at
Walgreens stores have been hit as consumers increasingly hunt
for bargains and shun higher-priced items.
For fiscal 2025, Walgreens said it expects adjusted earnings
of $1.40 to $1.80 per share, versus estimates of $1.73 per
share.
(Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb
Chakrabarty)